Browsing by Author Bourantas, K. L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 10 to 29 of 96 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin diseaseVassou, A.; Alymara, V.; Chaidos, A.; Bourantas, K. L.24-Nov-2015-
Bloodstream infections in adult patients with malignant blood disorders and neutropenia: Microbial spectrum and antimicrobial susceptibility patternLevidiotou, S.; Bouranta, P.; Gartzonika, C.; Papamichail, D.; Bourantas, K. L.24-Nov-2015-
Brucellosis-induced autoimmune hemolytic anemia treated with rituximabBourantas, L. K.; Pappas, G.; Kapsali, E.; Gougopoulou, D.; Papamichail, D.; Bourantas, K. L.24-Nov-2015-
C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Stebbing, J.; Bourantas, K. L.24-Nov-2015-
Childhood brucellosis in north-western Greece: a retrospective analysisGalanakis, E.; Bourantas, K. L.; Leveidiotou, S.; Lapatsanis, P. D.24-Nov-2015-
Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case reportBourantas, K. L.; Repousis, P.; Tsiara, S.; Christou, L.; Konstantinidou, P.; Bai, M.24-Nov-2015-
Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatmentMakis, A. C.; Hatzimichael, E. C.; Kolios, G.; Bourantas, K. L.24-Nov-2015-
Clinical correlation of bone marrow microvessel density in essential thrombocythemiaPanteli, K.; Zagorianakou, N.; Agnantis, N. J.; Bourantas, K. L.; Bai, M.24-Nov-2015-
Coexistence of myelodysplastic syndrome and multiple myelomaTsiara, S.; Economou, G.; Panteli, A.; Isaakidis, P.; Kapsali, E.; Bourantas, K. L.24-Nov-2015-
Combination therapy with interferon alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemiaBourantas, K. L.; Syrou, M.; Tsiara, S.; Danella, M.; Konstantinides, P.24-Nov-2015-
Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosisBourantas, K. L.; Tsiara, S.; Christou, L.; Repousis, P.; Konstantinidou, P.; Bai, M.; Seferiadis, K.24-Nov-2015-
Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosisBenetatos, L.; Chaidos, A.; Alymara, V.; Vassou, A.; Bourantas, K. L.24-Nov-2015-
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromesBenetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L.24-Nov-2015-
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patientBenetatos, L.; Hatzimichael, E.; Vassou, A.; Bourantas, K. L.24-Nov-2015-
Distribution and frequency of beta-thalassemia mutations in northwestern and central GreeceGeorgiou, I.; Makis, A.; Chaidos, A.; Bouba, I.; Hatzi, E.; Kranas, V.; Zilidis, C.; Bourantas, K. L.24-Nov-2015-
Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiproneAlymara, V.; Bourantas, D.; Chaidos, A.; Bouranta, P.; Gouva, M.; Vassou, A.; Tzouvara, E.; Bourantas, K. L.24-Nov-2015-
Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpuraBenetatos, L.; Vassou, A.; Bourantas, K. L.24-Nov-2015-
Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patientsBourantas, K. L.; Georgiou, I.; Seferiadis, K.24-Nov-2015-
Gamma-chain heterogeneity in Greek (delta beta)zero-thalassemiaGeorgiou, I.; Seferiadis, K.; Lolis, D.; Tsolas, O.; Bourantas, K. L.24-Nov-2015-
Glutathione sulfur transferase M1 and T1 genotypes in chronic lymphoblastic leukemiaTsabouri, S.; Georgiou, I.; Katsaraki, A.; Bourantas, K. L.24-Nov-2015-